Crystal Structure of 4—（4—chlorophenyl）—7,7—dimethyl—2,5—dioxo—1,2,3,4,5,6,7,8—octahydroquinoline

1 INTRODUCTION Since the discovery of the pharmacological effects of 1,4-dihydropridines(1,4-DHPs) as calcium channel blocks[1], a great deal of work has been directed towards synthesis of the novel 1,4-DHPs acting as calcium antagonists[2, 3]. In fact, it is well-established that slightly modified structures on the DHP exhibit a calcium agents effect[4, 5] ; however, two fused rings have been less well-studied. By refluxing equivalent amounts of dimedone, aromatic aldehyde Meldrum抯 …     

2,6-二甲基-4-苯基-1,4-二氢吡啶-3,5-二甲酸乙酯的合成和晶体结构

标题化合物C1 9H2 3NO4由苯甲醛、尿素、乙酰乙酸乙酯在微波辐射下干反应而得。结构通过单晶X 射线衍射法测定 ,其晶体属单斜晶系 ,空间群P2 1 /c ,a =9.745(2 ) ,b =7.388(2 ) ,c =2 4 .354(5) ,β =92 .60 (3)°,V =1 751 .6(6) 3,Z =4,Mr=32 9.38,Dc=1 2 4 9g/cm3,μ(MoKα) =0 .0 87mm- 1 ,F(0 0 0 ) =70 4。晶体结构用直接法解出 ,经全矩阵最小二乘法对原子参数进行修正 ,最终的偏离因子为R =0 .0 4 1 6,wR =0 .1 1 75。在晶体结构中 ,二氢吡啶环与苯环之间的二面角为 92 .1 4°。     

一种新型钌(Ⅱ)-组氨酸配合物[RuCl(Me2SO)2(L-His)]·H2O的合成及其结构表征

本文通过将抗癌活性化合物cis-[RuCl2(Me2SO)4]与L-组氨酸在乙醇溶液中或在溶剂热条件下反应,均得到了配合物[RuCl(Me2SO)2(L-His)](1).X-射线单晶结构分析表明该配合物的晶体属变形八面体,空间群P3121,a=b=14.0575(16)A,c=15.637(3)A,分子中含一个结晶水.该配合物中L-组氨酸配体分别通过氨基氮、咪唑氮、羧基氧与中心原子钌(Ⅱ)配位.     

Cd（Ⅱ）与HSA或BSA的结合平衡研究

用平衡透析法详细研究了生理pH(7.43)条件下Cd(Ⅱ)与HSA或BSA的结合平衡.通过非线性最小二乘法拟合Bjerrum方程,首次报道了Cd(Ⅱ)-HSA和Cd(Ⅱ)-BSA体系的逐级稳定常数值,其K_1～K_3的数量级均为10~4;Hill系数和自由能偶合定量分析表明Cd(Ⅱ)与HSA或BSA的结合均产生在类似体系中少见的强的正协同效应,且Cd(Ⅱ)与HSA结合产生的正协同效应大于BSA;Scatchard图分析表明,Cd(Ⅱ)在HSA和BSA中均有3个强结合部位.通过Cd(Ⅱ)与Cu(Ⅱ),Zn(Ⅱ)或Ca(Ⅱ)等竞争结合HSA或BSA的结果,进一步讨论了Cd(Ⅱ)在HSA或BSA中强结合部位的可能位置和(或)配体.     

稀土离子对大肠杆菌亮氨酰-tRNA合成酶动力学性质的影响

采用含ｐＴｒｅ－９９Ｂ／ｌｅｕＳ２转化子的高表达菌株,简便快速地提取、纯化大肠杆菌亮氨酰－ｔＲＮＡ｜＾ｅｕ与未脱镁ｔＲＮＡ｜＾ｅｕ对ＡＴＰ和亮 酸的表观Ｋｍ值明显不同。高浓度ＡＴＰ对脱镁tＰＮＡ显示抑制作用,说明金属离子是氨酰化反应的底物之一。     

氢中杂质CO对LaNi5,LaNi4.7Al0.3,MlNi4.5Al0.5合金PCT特性的影响

研究了 3种贮氢合金 ,即LaNi5 ,LaNi4.7Al0 .3,MlNi4.5 Al0 .5 在纯氢 ( 99 999% )及含 0 0 1%CO气体杂质氢中毒化前后的PCT特性。对于LaNi5 ,毒化后不出现平台 ;对LaNi4.7Al0 .3及MlNi4.5 Al0 .5 合金 ,平台压升高 ,平台倾斜加剧 ,平台宽度缩小 ,饱和吸氢量减小。LaNi5 中加入少量Al后 ,可以提高其抗毒化能力。分析了PCT平台变短、倾斜的原因。     

Binding Equilibrium Studies Between Co2+ and HAS or BSA

Introduction Up to now,the interactions of Cu2+,Ni2+ and Zn2+ with serum albumin have been extensively studied[1-3].However,the interaction of serum with Co2+ has rarely been studied.Our study of Co2+-HSA by means of charge transfer spectra indicated that the metal center took an octahedron configuration and the binding site was probably located at the tripeptide segment of the N-terminal of albumin[4].Sadler et al.[5]has reported that the binding site of Co2+ in HSA is located at the tripeptide segment of HSA involving the four nitrogen atoms and a carboxyl oxygen atom of Aspl.In this paper the interaction of HSA and BSA with Co2+ at physiological pH is further studied by equilibrium dialysis.The number of binding sites and the cooperation among the binding sites are reported.According to the equilibrium dialysis results and the study of competition between Co2+ and Cu2+,Ca2+ or Zn2+ to be bound to HSA or BSA,it is suggested that there are three strong binding sites in both HSA and BSA.The possible locations of the strong binding sites of Co2+ in HSA and BSA have also been determined.     

微量元素与优生的关系

研究表明,微量元素与优先有着非常密切的关系。如果微量元素缺乏,就会导致各种疾病甚至先天残疾的产生。     

聚硅氧烷/液晶复合膜的制备及其血液相容性研究

以含氢硅油和乙烯基硅油为基质,在氯铂酸催化下与胆甾醇油烯基碳酸酯液晶共混交联成一定强度的聚硅氧烷／液晶复合膜。借助偏光显微撞观察了不同液日含量在材料表面的状态,通过动态凝血实验、血小板粘附与变形实验、溶血实验等研究材料表面形态与血液相容性的关系。结果表明,含液晶２０％、３０％的液晶膜具有优良的抗凝血性能。     

气相色谱法测定溴己新血药浓度及药代动力学研究

建立了人血浆中溴己新的气相色谱 电子捕获测定法 ,对溴己新胶囊在健康人体内的药代动力学进行了研究。色谱柱为 5 %SE 30 (2m× 3mmi.d .)硅烷化玻璃柱。 5 氯 2 氨基二苯甲酮为内标 ,血浆样品加入磷酸盐缓冲液 (pH 6 0 )后用正己烷 二氯甲烷 (体积比为 9∶1)提取。线性范围为 1 0 μg/L～ 5 0 0 μg/L ,r =0 9994。人血浆中最小检测质量浓度为 0 5 μg/L。方法重现性好 ,日内、日间RSD分别小于 4 5 6 %和 7 11% ,平均回收率 97 5 %。 8名健康志愿者口服 8mg溴己新胶囊后 ,其体内代谢过程符合一房室模型。方法可用于体内血药浓度测定 ,简单、快速 ,灵敏度高 ,数据准确可靠